HIGH-DOSE INACTIVATED INFLUENZA VACCINE IS ASSOCIATED WITH COST SAVINGS AND BETTER OUTCOMES COMPARED TO STANDARD-DOSE INACTIVATED INFLUENZA VACCINE IN SENIORS

被引：0
|
作者：
Chit, A. [1 ]
Becker, D. L. [2 ]
Diazgranados, C. [1 ]
Maschio, M. [3 ]
Yau, E. [1 ]
Drummond, M. [4 ]
机构：
[1] Sanofi Pasteur, Swiftwater, PA USA
[2] Optum, Burlington, ON, Canada
[3] OptumInsight, Burlington, ON, Canada
[4] Univ York, York YO10 5DD, N Yorkshire, England
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 03期
关键词：
D O I：
10.1016/j.jval.2015.03.1399
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN75
引用
收藏
页码：A240 / A240
页数：1
相关论文
共 50 条
  • [1] High-dose inactivated influenza vaccine is associated with cost savings and better outcomes compared to standard-dose inactivated influenza vaccine in Canadian seniors
    Becker, Debbie L.
    Chit, Ayman
    DiazGranados, Carlos A.
    Maschio, Michael
    Yau, Eddy
    Drummond, Michael
    Human Vaccines & Immunotherapeutics, 2016, 12 (12) : 3036 - 3042
  • [2] HIGH-DOSE INACTIVATED INFLUENZA VACCINE CAN REDUCE COSTS AND IMPROVE OUTCOMES COMPARED TO STANDARD-DOSE INACTIVATED INFLUENZA VACCINE IN CANADIAN SENIORS
    Chit, A.
    Becker, D., I
    Diazgranailos, C. A.
    Maschio, M.
    Yau, E.
    Drummond, M.
    VALUE IN HEALTH, 2015, 18 (07) : A587 - A588
  • [3] Immunogenicity and safety of high-dose trivalent inactivated influenza vaccine compared to standard-dose vaccine in children and young adults with cancer or HIV infection
    Hakim, Hana
    Allison, Kim J.
    Van de Velde, Lee-Ann
    Tang, Li
    Sun, Yilun
    Flynn, Patricia M.
    McCullers, Jonathan A.
    VACCINE, 2016, 34 (27) : 3141 - 3148
  • [4] Better outcomes with high-dose trivalent influenza vaccine in seniors
    Machado, Marina A.
    Moura, Cristiano S.
    Abrahamowicz, Michal
    Ward, Brian J.
    Pilote, Louise
    Bernatsky, Sasha
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 88 - 89
  • [5] High-Dose Inactivated Influenza Vaccine Quadrivalent for Older Adults
    Chahine, Elias B.
    ANNALS OF PHARMACOTHERAPY, 2021, 55 (01) : 89 - 97
  • [6] High-dose trivalent inactivated influenza vaccine safe in elderly
    Reactions Weekly, 2020, 1816 (1) : 7 - 7
  • [7] Comparison of Side Effects of the 2015-2016 High-Dose, Inactivated, Trivalent Influenza Vaccine and Standard Dose, Inactivated, Trivalent Influenza Vaccine in Adults ≥ 65 Years
    Kaka, Anjum S.
    Filice, Gregory A.
    Myllenbeck, Sharon
    Nichol, Kristin L.
    OPEN FORUM INFECTIOUS DISEASES, 2017, 4 (01):
  • [8] Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or older: a randomized Phase III trial
    Pepin, Stephanie
    Nicolas, Jean-Francois
    Szymanski, Henryk
    Leroux-Roels, Isabel
    Schaum, Thomas
    Bonten, Marc
    Icardi, Giancarlo
    Shrestha, Anju
    Tabar, Cynthia
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (12) : 5475 - 5486
  • [9] Randomized Double-Blind Study of the Safety and Immunogenicity of Standard-Dose Trivalent Inactivated Influenza Vaccine versus High-Dose Trivalent Inactivated Influenza Vaccine in Adult Hematopoietic Stem Cell Transplantation Patients
    Halasa, Natasha B.
    Savani, Bipin N.
    Asokan, Ishan
    Kassim, Adetola
    Simons, Rhea
    Summers, Chelsey
    Bourgeois, John
    Clifton, Carey
    Vaughan, Leigh Ann
    Lucid, Catherine
    Wang, Li
    Fonnesbeck, Christopher
    Jagasia, Madan
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : 528 - 535
  • [10] Gastrointestinal Events in High-Dose vs Standard-Dose Influenza Vaccine Recipients
    Talbot, H. Keipp
    Dunning, Andrew J.
    Robertson, Corwin A.
    Landolfi, Victoria A.
    Greenberg, David P.
    DiazGranados, Carlos A.
    OPEN FORUM INFECTIOUS DISEASES, 2018, 5 (06):
12345